Prostate cancer is the
abnormal growth of cells in a man's
prostate gland. The prostate sits just below the bladder. It makes part of the
fluid for
semen. In young men, the prostate is about the size of
a walnut. It usually grows larger as you grow older.
Prostate
cancer is common in men older than 65. It usually grows slowly and can take
years to grow large enough to cause any problems. Most cases are treatable,
because they are found with screening tests before the cancer has spread to
other parts of the body.1 Although most men may die
with prostate cancer, most men do not die
from it.
Experts don't know what causes
prostate cancer, but they believe that your age, family history (genetics), and
race affect your chances of getting it. What you eat, such as foods high in
fats, may also play a part.2
What are the symptoms?
Prostate cancer usually
does not cause symptoms in its early stages. Most men don't know they have it
until it is found during a regular medical exam.
When problems are
noticed, they are most often problems with urinating. But these same symptoms
can also be caused by an enlarged prostate (benign prostatic hyperplasia). An enlarged prostate is common in older men.
See your doctor for a checkup if:
You have trouble starting your urine
stream.
You have a weaker-than-normal urine stream.
You
cannot urinate at all.
You have to urinate often.
You
feel like your bladder is not emptying completely when you
urinate.
You have to get up at night to urinate.
You
have pain or burning when you urinate.
You have blood in your
urine.
You have a deep pain in your lower back, belly, hip, or
pelvis.
How is prostate cancer diagnosed?
The most common
way to check for prostate cancer is to have a
digital rectal exam, in which the doctor puts a
gloved, lubricated finger in your rectum to feel your prostate, and a
prostate-specific antigen (PSA) blood test. A higher
level of PSA may mean that you have prostate cancer, but it could also mean
that you have an enlargement or infection of the prostate.
If your
PSA is high, or if your doctor finds anything during the rectal exam, he or she
may do a
biopsy to figure out the cause. A biopsy means your
doctor takes a sample of tissue from your prostate gland and sends it to a lab
for testing.
Because many men have regular checkups, about 9 out
of 10 prostate cancers are found in the early stages, with a 5-year survival
rate of almost 100%.1 The 5-year survival rate shows
the percentage of men still alive 5 years or longer after diagnosis. It's
important to remember that everyone's case is different, and these numbers may
not show what will happen in your case.
Should you have regular tests for prostate cancer?
It is important to have regular health checkups, including a digital
rectal exam. But experts disagree on whether regular PSA testing is right for
all men. Testing could lead you to have cancer treatment that can cause other
health problems, especially loss of bladder control and not being able to have
an erection.
So talk with your doctor. Ask about your risk for
prostate cancer, and discuss the pros and cons of PSA testing.
How is prostate cancer treated?
Your treatment
will depend on what kind of cancer cells you have, how far they have spread,
your age and general health, and your preferences.
You and your
doctor may decide to treat your cancer with surgery, radiation, hormone
therapy, or a combination. Or, if the cancer has not spread and you are around
age 70 or older, you may be able to
wait and watch to see what happens. During watchful
waiting, you will have regular checkups with your doctor to see if your cancer
has changed.
Choosing treatment for prostate cancer can be
confusing. Talk with your doctor to choose the treatment that is best for you.
How can treatment affect your quality of life?
Your age and overall health will make a difference in how treatment may
affect your quality of life. Any health problems you have before you are
treated, especially urinary, bowel, or sexual function problems, will affect
how you recover.
Both surgery and radiation can cause
urinary incontinence (not being able to control
urination) or impotence (not being able to have an erection). The level of
urinary incontinence and how long it lasts and the quality of the erections a
man has after treatment will depend on whether the cancer has spread. These
also depend on what treatment is used.
Nerves that help a man
have an erection are right next to the prostate. Surgery to remove the cancer
may damage these nerves. Many times a special form of surgery, called
nerve-sparing surgery, can preserve the nerves. But if the cancer has spread to
the nerves, they may have to be removed during surgery.
These
same nerves can also be damaged by the X-rays that are used in radiation
therapy.
Medicines and mechanical aids may help men who are
impotent because of treatment. Some men recover part or most of their ability
to have an erection several months or even years after surgery.
The exact cause of
prostate cancer is not known, but experts believe that
your age and family history (genetics) may have something to do with your
chances of getting the disease. What you eat may add to your chances of getting
it.2
The prostate usually gets larger as
you age. Having an enlarged prostate (benign prostatic hyperplasia, or BPH) is very common among older men and does not
increase your chances of developing prostate cancer. But an enlarged prostate
is sometimes caused by prostate cancer instead of BPH.
Symptoms
Prostate cancer usually doesn't cause
symptoms in its early stages. When there are symptoms, they may include:
Having difficulty starting your urine stream.
This is called hesitancy.
Having a weaker-than-normal urine
stream.
Not being able to urinate at all.
Having to
urinate often.
Feeling that your bladder is not emptying completely
when you urinate.
Having to get up at night to urinate. This is
called nocturia.
Having pain or a burning feeling when you urinate.
This is called dysuria.
Having blood in your urine. This is called
hematuria.
Having blood in your
semen. This is called
hematospermia.
Having a deep pain in your lower back, abdomen, hip,
or pelvis.
These symptoms may also be caused by:
Benign prostatic hyperplasia (BPH), which is an enlarged prostate. This is very common in
older men. The prostate usually grows larger with age. When it gets large
enough, it can press against the urethra-the tube that carries urine from the
bladder through your penis-and cause bladder problems.
Almost all
prostate cancers are discovered in their early stages,
and the 5-year survival rate is almost 100% when the cancer is found at an
early stage.1 The 5-year survival rate is the
percentage of men who are still alive 5 years after they have been diagnosed.
It is just an average. Everyone's case is different, and this number may not
show what will happen in your case.
Prostate cancer is so common
that some experts believe that every man would get it if he lived long enough.
Studies of autopsies show that most men older than 85 who die of other causes
have tumors in their prostates.3 It usually is a very
slow-growing cancer that takes years to grow large enough to cause any
problems. Sometimes, though, it grows quickly.
When prostate
cancer spreads, it goes first to surrounding tissue, then to
lymph nodes in the pelvis, and then on to the bones, lungs, or other organs.
For more information, see the topic
Prostate Cancer, Advanced or Metastatic.
What Increases Your Risk
Being older than 50 is the
main risk factor for
prostate cancer. A risk factor is anything that makes
you more likely to get a particular disease. More than 65% of new prostate
cancers are diagnosed in men who are 65 or older.1 In
addition, 90% of prostate cancer deaths occur in men who are older than
65.4
Your chances of getting the disease
are higher if other men in your family have had it. Your risk is doubled if
your father or brother developed prostate cancer. Your risk also depends on the
age at which your relative was diagnosed.3 But most
men who get prostate cancer have no family history of the disease.
Men whose families carry the gene changes that cause breast cancer,
BRCA1 or BRCA2, are thought to be at increased risk for prostate
cancer.5
Race and prostate cancer survival
African-American men and Jamaican men of African descent have a greater chance
of getting the kind of prostate cancer that grows and spreads. Experts believe
that there are many reasons for the differences in the prostate cancer disease
and death rates among different races and around the world.6 One reason is a genetic link. Researchers have recently
discovered a gene that occurs more often in African-American men and raises
their risk of prostate cancer. Other genes may be involved too. It is hoped
that these findings will lead to new treatments.7
Ethnicity and 5-year survival rate (percentage of men with prostate cancer who survive for 5 years or
longer)8
Survival rates
Diagnosis
Caucasian
African-American
Cancer that has not spread
95%
88%
Locally advanced cancer
87%
69%
Metastatic cancer
30%
23%
The 5-year survival rate shows the percentage of men who
are still alive 5 years or more after they are diagnosed. It is important to
remember that these are only averages. Everyone's case is different, and these
numbers may not show what will happen in your case.
Asian-American
men develop prostate cancer more often than Asian men living in Japan and
China. But the incidence of prostate cancer in Asian-American men is lower than
that in Caucasian men and much lower than that in African-American men. A
Western high-fat diet may be the cause.2
Other factors that may increase your risk
What you eat. Men who live in countries where
people eat more red meat and fats are more likely to be diagnosed with and die
from prostate cancer, according to some studies. Eating more lycopene, found in
tomatoes and beets, may decrease the risk. Getting enough selenium and vitamin
E may also help.2
Hormones. Researchers are studying the link between
high
testosterone levels and prostate cancer.6
Where you live. There are places in the world
where the rates of prostate cancer are low, such as in Japan or China. But when
Japanese or Chinese men move to countries where the rate is higher, such as the
United States, their rates go up.2
When To Call a Doctor
Call your doctor immediately if you:
Are completely unable to
urinate.
Have painful urination and a fever higher than
100
°F (38
°C), chills, or body
aches.
Have blood or pus in your urine.
Call your doctor if you have painful urination and signs of
a possible
urinary tract infection that last longer than 24
hours. These signs include:
A burning sensation while
urinating.
Pain in your lower back just below your ribs that is not
related to any injury or physical exertion.
Painful
ejaculation.
Difficulty starting or controlling your
urination.
Call your doctor to schedule an appointment within 1 to 2
weeks if you have unexplained:
Weight loss.
Dull, aching pain in
your lower back, hip, or pelvis.
In most men, the
prostate gland gets larger as they get older. Having symptoms of an enlarged
prostate does not mean you have cancer, but you should be checked by your
doctor. Symptoms of an enlarged prostate include difficulty urinating and
sexual dysfunction, among others. For more information on an enlarged prostate,
see the topic
Benign Prostatic Hyperplasia (BPH).
The main reason to choose watching and
waiting is to avoid the potentially serious side effects of
surgery or
radiation. With treatment there is a chance that you
will have erection problems and bladder problems and also a small chance that
you will have bowel problems. Some men whose cancer has been caught in its
early stages choose to watch and wait because most prostate cancer grows
slowly. This choice makes the most sense for some men in their 70s or 80s or
men who are in poor health.
The main reason to choose treatment
(and not watchful waiting) is that it makes the cancer much less likely to grow
and spread.9
During watchful waiting, you have regular
digital rectal exams and
PSA tests to check the growth of your cancer. As long
as there is no change, you may continue to watch and wait. If the cancer begins
to grow rapidly or spread, you may consider other treatment.
Who To See
The following health professionals can evaluate
urinary symptoms:
You may want to get a second opinion from a different
specialist before making your treatment decision. For example, if your doctor
is a family medicine physician, you may want to talk to a radiation oncologist,
urologist, or medical oncologist.
If you are having problems urinating,
your doctor may use tests to see if you have an enlarged prostate (benign prostatic hyperplasia). This condition is the most common cause of urination
problems.
Initial tests include:
A
digital rectal exam, in which the doctor inserts a
gloved finger into your rectum to feel your prostate gland. Some prostate
tumors can be found this way.
A
urine test, in which some of your urine is sent to a
lab and checked for blood, infection, or abnormal cells.
Prostate cancer can cause blood in the
urine.
A
PSA test to measure the levels of prostate-specific
antigen (PSA) in your blood. A higher level of PSA may be a sign of an
enlargement, infection, or cancer of the prostate. If it is possible that an
infection is raising your PSA, you may first have 4 to 6 weeks of
antibiotics. Your doctor may suggest a second PSA test
before thinking of doing a biopsy.
AUA symptom score.
This is a series of questions from the American Urological Association (AUA)
that measures how bad your urinating problems are. Sometimes these problems are
caused by prostate cancer that is blocking your urine flow.
Urine-flow rate test. This test measures your urine and how fast
it comes out. Sometimes a low flow rate is caused by prostate cancer.
If tests point to prostate cancer,
your doctor may recommend a
prostate biopsy, in which tissue is taken from the
prostate and examined under a microscope. A biopsy is the only way to confirm
whether you have prostate cancer.
After treatment for prostate cancer, you have regular checkups to check for any signs
that the cancer has come back or spread. Tests that are done to evaluate the
spread of the cancer and to plan further treatment may include:
Blood tests. Different types of blood tests are
used to see whether cancer has spread to your bones or liver.
A
bone scan. Radioactive material that shows up on
X-rays is injected into your arm. An X-ray camera passes over your body, taking
pictures as the radioactive material moves into your bones. Areas of bone
damage show up in the pictures. Prostate cancer that has spread to the bones
can cause this kind of damage.
A
CT scan. A CT scanner directs a series of X-rays
through your body. CT scans can show tissue damage or diseases, such as an
infection or tumor.
A pelvic lymphadenectomy. This is an operation
in which the
lymph nodes near your prostate are removed and checked under a microscope to
see if they contain cancer. It may be done at the same time as surgery to
remove your prostate.
An
MRI. An MRI uses a strong magnetic field to make
pictures of the prostate. The MRI can show tissue damage or disease, such as
infection or a tumor.
ProstaScint scan. This scan may be used to
look for cancer cells after you have had surgery to remove cancer. Radioactive
material that attaches itself to prostate cancer cells and shows up on X-rays
is injected into a vein. Four days later, your body is scanned with a special
camera, and lymph nodes and other areas that have been invaded by prostate
cancer cells show up in the picture.
PET scan.
This kind of scanner produces 3-D images that give a better view of tumors. In
rare cases, it is used to look at advanced prostate cancer.
Early Detection
Screening for prostate cancer-checking for signs
of the disease when there are no symptoms-is done with the digital rectal exam
and the PSA test. In the United States, about 75% of men who are age 50 or
older have had a PSA test.10
The number of deaths caused by prostate cancer has
dropped over the past 20 years. This has been linked to more early diagnosis
with PSA testing and to better cancer treatment.1
Finding prostate cancer early leads you to some
big decisions. Most prostate cancer grows slowly. And the side effects of
treatment can change your quality of life-mainly not being able to have an
erection (impotence) and not being able to control urination (incontinence). If
you are around age 70 or older, these side effects may seem worse than
early-stage cancer that may not grow much during your lifetime. But, especially
for men 65 or younger, treatment makes the cancer less likely to grow and
spread.9
Because your age and medical
history are unique, it is important to learn the pros and cons of PSA testing
and talk to your doctor before making a decision.
What to think about
It is expected that
prostate cancer will account for 29% (218,890) of new cancer cases in men in
the United States in 2007. About 90% of those will be discovered in the early
stages, and the overall 5-year survival rate for men whose cancer is found
early is almost 100%.1
Treatment Overview
Prostate cancer
is often curable. About 90% of new cases of prostate cancer are caught early.
Almost 100% of men with these early cancers survive 5 years or more after being
diagnosed.1
Choosing treatment for
prostate cancer can be confusing. Any treatment can cause serious side
effects.
Watchful waiting may
be a good option if you are around age 70 or older. During watchful waiting,
you have regular checkups with your doctor to see if your cancer has changed.
In general, healthy men who are younger than 60 and whose cancer
has not spread are treated with surgery or radiation. Surgery removes the
prostate gland and its cancer. Radiation destroys the cancer and may damage
nearby healthy cells. With these treatments, there is a chance of having
erection problems, some chance of having urine leakage problems, and a small
chance of having bowel problems.
Because of these side effects,
some men, especially some older men, may decide that the cure is worse than the
disease. Studies show that some men are willing to accept the risk of a shorter
life span in return for a better quality of life than what they would have with
treatment.11
Your treatment decision will
depend on:
Your age.
Any serious health problems, including any
urinary, bowel, or sexual function problems.
What kind of cancer cells you
have. This is called the
grade or Gleason score of your cancer. Most prostate
cancer cells grow very slowly, but some types of cells grow quickly and spread
to other areas of the body.
How far your cancer has spread. This
is called the
stage of your cancer.
The side effects of
treatment.
Your personal feelings and concerns.
Prostate cancer is curable if it is detected and treated
early. Unlike many other cancers, it is usually slow-growing. Most men will die
with prostate cancer but not of
prostate cancer. This slow growth means you have time to learn all you can
before deciding whether to have treatment or which treatment to have.
Initial treatment
The main choices for treating
prostate cancer include prostatectomy, radiation,
cryotherapy, hormone therapy, and watchful waiting.
Surgery involves
removing the cancer by removing the prostate gland. This operation is called a
prostatectomy. Before removing the prostate, the surgeon may remove some
lymph nodes in the area to see if the cancer has spread.
Nerve-sparing surgery helps preserve
the nerves that are along the side of the prostate and that are needed for an
erection. This surgery is only done when there is little chance of leaving
cancer cells behind. If you already have sexual function issues, nerve-sparing
surgery may not be the best choice for you.
Laparoscopic radical prostatectomy is surgery done through
several very small incisions in the belly. Laparoscopic surgery is done with a
tiny camera and special instruments to remove the prostate.
Robotic-assisted laparoscopic radical prostatectomy is surgery
done through small incisions in the belly with robotic arms that translate the
surgeon's hand motions into finer and more precise movements. This surgery
requires specially trained doctors. With an surgeon who does a large number of
these procedures, men who have this procedure heal more quickly and report
fewer problems with impotence and incontinence.12
Radiation treatments,
which include external and internal radiation, have been improved with newer
technologies that reduce side effects and other problems caused by radiation in
the past.
External radiation. Also called external beam radiotherapy, or EBRT, radiation
therapy uses high-energy rays, such as X-rays, to destroy the cancer. It is
usually given in multiple doses over several weeks. Radiation destroys tissue,
so it may damage the nerves along the side of the prostate that affect your
ability to have an erection. If you already have bowel problems, external
radiation may make your symptoms worse. The three most common forms of external
radiation are listed here:
Conformal radiotherapy (3D-CRT)
uses a three-dimensional planning system to target a strong dose of radiation
to the prostate cancer. This helps to protect healthy tissue from
radiation.
Intensity-modulated radiation therapy (IMRT) uses a carefully adjusted amount of radiation. This protects
healthy tissue more than conformal radiotherapy does.
Proton therapy uses a different type of energy (protons)
rather than X-rays. This allows a higher amount of specifically directed
radiation, which protects nearby healthy tissue the most, especially the
rectum.13 Sometimes proton therapy is combined with
X-ray therapy.
Internal radiation (brachytherapy). Brachytherapy is a one-time radiation treatment that
uses tiny radioactive seeds. After you are given anesthesia, the doctor uses a
needle to inject the seeds into your prostate, where they slowly release
radiation directly into the cancer. Sometimes external radiation or hormone
therapy is added to brachytherapy. If you already have urinary problems,
brachytherapy may make your symptoms worse.
High-dose rate brachytherapy (HDR brachytherapy). For this form of brachytherapy, radioactive material is
placed into the prostate for a very brief period of time (seconds to minutes)
and then removed. The radiation is delivered this way several times. Early
results from studies show that HDR brachytherapy is as helpful as other kinds
of internal radiation.14
Cryosurgery, also called cryoablation, freezes the
prostate gland to kill the cancer. This is often done when surgery is not an
option and when the cancer is advanced but still inside the prostate gland. And
the results, including side effects such as
incontinence or an injury to the
rectum, depend very much on the doctor's skill and
experience. Cryosurgery may not work as well as prostatectomy or external
radiation, but the long-term results are not yet known. With cryosurgery, the
prostate gland is not removed.
Hormone therapy, also
called androgen deprivation therapy or (ADT), is used in most cases with either
surgery or radiation. Hormone therapy by itself does not have survival rates
that are as good as combined therapies.15 Hormone
therapy cannot cure prostate cancer. But it will usually shrink the tumor and
slow the rate of cancer growth, sometimes for years. Taking a hormone-therapy
medicine lowers your level of testosterone and other male hormones. Another way
to lower male hormones is by having surgery to remove the testicles, called an
orchiectomy.
Watchful waiting
is a treatment choice, especially among men who are age 70 or older. This is a
period of time during which you are checked and tested regularly by your doctor
but you are not being treated. This choice may be good if you are in your later
years, tests show your cancer has been caught early and is the slow-growing
kind, and you do not want to have the side effects of surgery or
radiation.
The side effects of treatment are
important to think about. Removing the prostate gland during surgery can cause
impotence (not being able to have an erection) and
urinary incontinence (not being able to control
urination). Destroying the prostate gland with radiation may cause impotence
and incontinence, but not as much as surgery can. But radiation sometimes
causes diarrhea and bowel problems.2 Hormone therapy
can cause loss of sex drive and erections, risk of weak bones (osteoporosis),
hot flashes, and weight gain.
The ability
to have an erection sometimes returns or at least improves over time. So does
the ability to control urine leakage.
A diagnosis of prostate cancer usually means that you
will be seeing your doctor regularly for years to come, so it is a good idea to
build a relationship that is based on full and honest information. Ask your
doctor
questions about your cancer so that you can make the
best decision about treatment. Your doctor also may give you some advice on
changes to make in your life to help treatment be successful.
Your
treatment options will be different if you are diagnosed with prostate cancer
that has come back or has spread outside the prostate. For more information,
see the topic
Prostate Cancer, Advanced or Metastatic.
Dealing with your emotions
You may
feel many emotions after being diagnosed with prostate cancer. Most men feel
some denial, anger, and grief. There is no "normal" or "right" way to react.
There are many things you can do to help yourself deal with your
emotional reaction to prostate cancer. Talking with
family and friends helps some people. Others find that they need to spend time
alone.
If your reaction is interfering with your ability to make
decisions about your health, it is important to talk to your doctor. Your
cancer treatment center may offer psychological or financial services. You may
also contact your local chapter of the American Cancer Society to help you find
a support group. Talking with other men who have had similar feelings can be
very helpful.
For more information about specific treatments, see
the following topics:
If you choose surgery or
radiation to treat your
prostate cancer, it will be important to have regular
checkups. If your cancer comes back, this will help your doctor catch it early.
It will also help your doctor treat any complications you may have from your
treatment. Your regular follow-up program may include:
Physical exams.
PSA tests, to
measure the levels of prostate-specific antigen (PSA) in your blood. A higher
level of PSA may indicate an enlargement, infection, or cancer of the prostate.
A rising PSA level after treatment for prostate cancer can mean your cancer has
come back.
Prostate cancer and its treatment also may cause nausea,
pain, or other side effects. You can use
home treatment to manage some of these side effects. If you experience
nausea, wait for 1 hour after vomiting has stopped and
then sip a
rehydration drink to restore lost fluids and
nutrients. Your doctor may prescribe
medicines to control nausea and vomiting.
Constipation and
diarrhea may be eased if you drink enough fluids.
For more information about managing pain, see the topic
Cancer Pain.
If you decide to watch and
wait instead of having treatment, you will have regular checkups with your
doctor to check on your cancer. You will have digital rectal exams and PSA
tests every 3 to 6 months. It is possible that a curable cancer could spread
and become incurable during a 6-month period, but this is not common. If there
is no change in your condition, you may continue to watch and wait. If the
cancer begins to grow or spread, you may consider medicines, surgery, or
radiation.
Another treatment used in Europe
and Canada is high-intensity focused ultrasound (HIFU).
HIFU uses an intense heat from focused sound waves to kill cancer cells. HIFU
is also used for men who have cancer inside the prostate but who cannot have
surgery. With time, studies will show if HIFU works as well as surgery and/or
radiation therapy. HIFU is not yet FDA-approved for use in the United
States.
Age is not a reason to avoid surgery. But if you are 70 or
older, other medical conditions, such as
heart disease, may affect your decision. Men who are
older also have a higher rate of incontinence and impotence after surgery. Age
is especially important to think about if you have early-stage cancer, which
generally grows slowly.
Get a second or even a third opinion
before making your treatment decisions. You may hear differing advice or
opinions, which may seem confusing. But talking with other doctors can help you
make your decision. If your doctor is a medical oncologist, you may want to
talk with other prostate cancer specialists, such as a urologist, a radiation
oncologist, or a surgeon.
Studies show that fewer side effects are
reported at large medical centers, where the surgeons do prostatectomies more
often and so are more experienced and skilled.2
Prevention
You can take steps that may lower your
chances of getting
prostate cancer.11
Eat more low-fat, high-fiber foods, or foods with omega-3 fatty acids,
such as:
Soy products, like tofu and soy
beans.
Tomatoes and foods that contain tomato
sauce.
Vegetables like broccoli, cauliflower, and
cabbage.
Fish, like salmon, albacore tuna, and
sardines.
Walnuts and flaxseed, and their oils.
Researchers are looking into other things that may help
prevent prostate cancer. These include:
Supplements, such
as vitamins D and E, and selenium.
Home Treatment
During any stage of
prostate cancer, there are things you can do at home
to help manage the side effects of cancer or treatment. See the following tips
for managing:
Pain. You may wish to try taking aspirin or
similar drugs or an alternative therapy such as
biofeedback to help relieve your pain. Be sure to
discuss with your doctor any home treatments you use for pain.
Diarrhea. Do not eat until you are feeling better.
Take small sips of water or a rehydration drink often and small bites of salty
crackers. Begin eating mild foods (such as rice, dry toast or crackers,
bananas, broth, and applesauce) the next day or sooner, depending on how you
feel.
Constipation. Make sure you drink enough liquids. Most
adults should drink 8 to 10 glasses of water, or noncaffeinated beverages each
day. Include fruits, vegetables, and fiber in your diet each day.
Sleep problems. Often, simple measures such as having
a regular bedtime, getting some exercise during the day, and having no caffeine
late in the day can help with sleep problems.
Urinary problems. Home treatment for urinary incontinence includes eliminating
caffeinated drinks from your diet and setting a schedule of urinating every 3
to 4 hours, regardless of whether you feel the need. Try doing
pelvic floor (Kegel) exercises to strengthen your
pelvic muscles.
During your treatment, you may experience emotional
problems. See the following tips for managing:
Stress. Expressing your feelings to
others may help you understand and cope with them. Learning relaxation
techniques may also be helpful.
Poor body image.
Your feelings about your body may change after treatment for cancer. Talk
openly about your concerns with your partner, and discuss your feelings with
your doctor, who may also be able to refer you to organizations that can offer
additional support and information.
Healthy habits such as eating right and getting enough
sleep and exercise can help control your symptoms.
You should not
have to accept pain as part of having cancer treatment or having cancer. For
tips on pain management, see:
Hormones are drugs that can affect the growth of
prostate cancer cells.
Hormone therapy is sometimes used with radiation
treatment or surgery to help make sure that all cancer cells are
destroyed.
Chemotherapy is the use of powerful
drugs-either injected or taken as pills-to destroy cancer cells. Many men
decide to have chemotherapy for treatment of late-stage prostate cancer, but
researchers are studying whether chemotherapy should be used before or after
surgery to treat early-stage, high-risk prostate cancer.11
Surgery
Surgery is one of two main treatments for
early-stage
prostate cancer. Radiation is the other. Surgery may
be done to remove the prostate and its cancer. It may done to remove and test
lymph nodes in the area to see whether the cancer has spread. It also may be
done to fix urinary problems that are caused by a tumor pressing on the
urethra.
The
stage of your prostate cancer along with your age and
general health will affect the type of surgery you choose.
Surgery Choices
Radical prostatectomy is an operation
to remove the entire prostate and any nearby tissue that may contain cancer. It
can be done as open surgery through an incision (cut) in the belly, or as
laparoscopic surgery through several very small
incisions in the belly. Laparoscopic surgery is done with a tiny camera and
special instruments to remove the prostate. Sometimes lymph nodes in the area
also are removed so that they can be checked for signs of cancer. This is
called a
lymph node biopsy
Nerve-sparing surgery helps preserve the nerves that are along
the side of the prostate and that are needed for an erection. This is only done
when there is little chance of leaving cancer cells behind. If you already have
sexual function issues, nerve-sparing surgery may not be the best choice for
you.
Laparoscopic surgery is most often
done by hand. A few doctors now do this surgery by guiding robotic arms that
hold the surgery tools. This is called robot-assisted prostatectomy.
What To Think About
Removing the prostate can cause
erection problems and bladder problems. But for many men, these problems get
better over time. If you decide to have surgery, find a surgeon who does at
least 40 prostate surgeries a year. Studies show that men have fewer side
effects from surgery when they have a skilled and experienced surgeon.16
Surgery may completely remove your prostate
cancer. But it is not possible to know for sure before surgery whether the
cancer has spread beyond the prostate. When cancer has spread, it cannot always
be cured with surgery alone.
Other Treatment
Radiation therapy
Radiation therapy may be used alone or combined with
hormone treatment or surgery to treat
prostate cancer. Like surgery, it is most effective in
treating cancer that has not spread outside the prostate. When combined with
surgery, radiation is used to destroy any cancer cells that might be left
behind and to relieve pain when the cancer has spread.
There are
two main types of radiation treatment for prostate cancer:
External beam radiation, in which a machine
aims high-energy X-rays or protons at the cancer from outside the body.
External radiation also includes conformal radiotherapy, intensity-modulated
radiation therapy, and proton therapy.
Conformal radiotherapy (3D-CRT) uses a
three-dimensional planning system to target a strong dose of radiation to the
prostate cancer. This helps to protect healthy tissue from
radiation.
Intensity-modulated radiation therapy (IMRT) uses a carefully adjusted amount of radiation. This provides even
more protection for healthy tissue than conformal radiotherapy.
Proton therapy uses a different type of
energy (protons) rather than X-rays. This allows a higher amount of
specifically directed radiation, which offers the most protection possible to
nearby healthy tissue, especially the rectum.13
Sometimes proton therapy is combined with X-ray therapy.
Brachytherapy, in which tiny seeds containing
radioactive material are injected directly into or near the cancer and left
there. In time, the material loses its radioactivity and the seeds can remain
where they are.
Side effects
Radiation treatment may cause
erection problems and
bladder problems. It sometimes causes diarrhea. The
ability to have an erection sometimes returns or at least improves over time.
So does the ability to control urination.
Side effects are common.
Some men develop long-term problems that may have a big impact on the quality
of their lives. Long-term problems that can be caused by radiation treatment
include:
An irritated
rectum that can cause an urgent need to pass stool.
This is called proctitis.
An inflamed bladder and urination
problems. This is called cystitis.
An inflamed intestine and
diarrhea. This is called enteritis.
Being unable to have an
erection. This is called impotence.
Being unable to control
urination. This is called incontinence.
Painful urination. This is
called dysuria.
Immunotherapy
Researchers also are testing many new ways to treat prostate cancer using
the body's
immune system to destroy the cancer cells. This type
of treatment is called immunotherapy. Much has been
learned in the past 20 years about the body's ability to attack prostate cancer
cells with help from the outside, and research is still being done in this
area. This type of treatment either stimulates your immune system or adds to
it, for example, by giving you immune cells from another person.
Complementary therapy
Complementary
therapies, such as
acupuncture,
herbs,
biofeedback,
meditation,
yoga, and
vitamins, are sometimes used along with medical
treatment. Some people feel that they benefit from some of these therapies.
Before you try a complementary therapy, talk to your doctor about
its possible value and side effects. Let your doctor know if you are already
using any such therapies. Complementary therapies are not meant to take the
place of standard medical treatment, but they may improve your quality of life
and help you deal with the stress and side effects of cancer treatment.
Clinical trials
Clinical trials are
being run to find ways to prevent, detect, diagnose, and treat prostate cancer.
For example, researchers are studying whether vitamin E and selenium, which is
a mineral found in certain foods, can prevent prostate cancer.
The American Cancer Society's Man to Man program
provides community-based education and support for men with prostate cancer.
Self-help and support groups focus on prostate cancer, treatment, side effects,
and coping with the disease and with treatment.
Program services
and activities depend on the location. Some locations offer groups for men
along with their wives or partners. And other locations may offer a group
setting called Side by Side for the wives or partners to meet separately.
To locate a program in your area, call the American Cancer
Society toll-free at the number shown above.
National Cancer Institute (NCI)
NCI Publications Office
6116 Executive Boulevard
Suite 3036A
Bethesda, MD 20892-8322
Phone:
1-800-4-CANCER (1-800-422-6237) 9:00 a.m. to 4:30 p.m. EST, Monday through Friday
TDD:
1-800-332-8615
E-mail:
cancergovstaff@mail.nih.gov
Web Address:
www.cancer.gov (or
https://cissecure.nci.nih.gov/livehelp/welcome.asp# for live help
online)
The National Cancer Institute (NCI) is a U.S. government agency
that provides up-to-date information about the prevention, detection, and
treatment of cancer. NCI also offers supportive care to people with cancer and
to their families. NCI information is also available to doctors, nurses, and
other health professionals. NCI provides the latest information about clinical
trials. The Cancer Information Service, a service of NCI, has trained staff
members available to answer questions and send free publications.
Spanish-speaking staff members are also available.
National Prostate Cancer Coalition
1154 Fifteenth Street, Northwest
Washington, DC, 20005
Phone:
1-888-245-9455 toll-free (202) 463-9455
Fax:
202-463-9456
E-mail:
info@fightprostatecancer.org
Web Address:
www.fightprostatecancer.org
This organization works to reduce the number of cases of prostate
cancer through awareness, outreach, and advocacy. The organization also works
with government officials to increase federal funding for prostate cancer
research.
UrologyHealth.org, American Urological
Association
UrologyHealth.org is a Web site written by urologists
for patients. Visitors can find specific topics by using the "search"
option.
The Web site provides information about adult and
pediatric urologic topics, including kidney, bladder, and prostate conditions.
You can find a urologist, sign up for a free quarterly newsletter, or click on
the Urology Resource Center to find materials about urologic problems.
American Cancer Society (2006). Cancer Facts and Figures 2006, pp. 1-56. Atlanta: American
Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.
Kantoff PW (2007). Prostate cancer. In DC Dale, DD
Federman, eds., ACP Medicine, section 12, chap. 9. New
York: WebMD.
Gronberg H (2003). Prostate cancer epidemiology.
Lancet, 361(9360): 859-864.
U.S. Preventive Services Task Force (2003). Screening
for prostate cancer: Recommendations and rationale. American Family Physician, 67(4): 787-792.
National Institutes of Health (2007). Prostate cancer genetics: Fact sheet. Available online: http://www.nih.gov/about/researchresultsforthepublic.
Klein EA, et al. (2007). Epidemiology, etiology, and
prevention of prostate cancer. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2854-2873.
Philadelphia: Saunders Elsevier.
Robbins C, et al. (2007). Confirmation study of
prostate cancer risk variants at 8q24 in African Americans identifies a novel
risk locus. Genome Research, 17(12):
1717-1722.
National Cancer Institute (2007). Prostate Cancer (PDQ): Prevention-Health Professional Version.
Available online:
http://www.nci.nih.gov/cancertopics/pdq/prevention/prostate/HealthProfessional.
Bill-Axelson A, et al. (2005). Radical prostatectomy
versus watchful waiting in early prostate cancer. New England Journal of Medicine, 352(19): 1977-1984.
Punglia RS, et al. (2003). Effect of verification bias
on screening for prostate cancer by measurement of prostate-specific antigen.
New England Journal of Medicine, 349(4):
335-342.
Scher HI, et al. (2005). Cancer of the prostate. In VT
DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., pp. 1192-1259. Philadelphia: Lippincott Williams
and Wilkins.
Badani KK, et al. (2007). Evolution of robotic radical
prostatectomy: Assessment after 2,766 procedures. Cancer, 110(9): 1951-1958.
Brada M, et al. (2007). Proton therapy in clinical
practice: Current clinical evidence. Journal of Clinical Oncology, 25(8): 965-970.
D'Amico AV, et al. (2007). Radiation therapy for
prostate cancer. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 3006-3031. Philadelphia: Saunders
Elsevier.
Iversen P, et al. (2004). Bicalutamide (150 mg) versus
placebo as immediate therapy alone or as adjuvant to therapy with curative
intent for early nonmetastatic prostate cancer: 5.3-year median followup from
the Scandinavian Prostate Cancer Group Study No. 6. Journal of Urology, 172(5, Part 1): 1871-1876.
Agency for Healthcare Research and Quality (2008).
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Executive Summary (AHRQ Pub. No. 08-EHC010-1).
Rockville, MD: Agency for Healthcare Research and Quality. Available online:
http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=9&DocID=79.
Other Works Consulted
Agency for Healthcare Research and Quality (2008).
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Executive Summary (AHRQ Pub. No. 08-EHC010-1).
Rockville, MD: Agency for Healthcare Research and Quality. Available online:
http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=9&DocID=79.
Ahmed HU, et al. (2007). Will focal therapy become a
standard of care for men with localized prostate cancer? Nature Clinical Practice Oncology, 4(11): 632-642.
Chen RC, et al. (2008). Treatment "mismatch" in early
prostate cancer: Do treatment choices take patient quality of life into
account? Cancer, 112(1): 61-68.
D'Amico, et al. (2008). Androgen suppression and
radiation vs radiation alone for prostate cancer: A randomized trial.
JAMA, 299(3): 289-295.
Elkord E (2007). Immunology and immunotherapy
approaches for prostate cancer. Prostate Cancer Prostatic Disease, 10(3): 224-236.
Hartke DM, Resnick MI (2007). Radical perineal
prostatectomy. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2979-2984. Philadelphia: Saunders
Elsevier.
Iversen P, et al. (2004). Bicalutamide (150 mg) versus
placebo as immediate therapy alone or as adjuvant to therapy with curative
intent for early nonmetastatic prostate cancer: 5.3-year median followup from
the Scandinavian Prostate Cancer Group Study No. 6. Journal of Urology, 172(5, Part 1): 1871-1876.
National Comprehensive Cancer Network and the American
Cancer Society (2007). Clinical Practice Guidelines in Oncology: Prostate Cancer, V.2.2007. Jenkintown, PA: National
Comprehensive Cancer Network. Available online:
http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
National Institutes of Health (2007). Prostate cancer genetics: Fact sheet. Available online: http://www.nih.gov/about/researchresultsforthepublic.
Redman MW, et al. (2008). Finasteride does not
increase the risk of high-grade prostate cancer: A bias-adjusted modeling
approach. Cancer Prevention Research. Published online
May 18, 2008 (doi:10.1158/1940-6207.CAPR-08-0092).
Su L, Smith JA (2007). Laparoscopic and
robotic-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy.
In AJ Wein et al., eds. Campbell-Walsh Urology, 9th ed.,
vol. 3, pp. 2985-3005. Philadelphia: Saunders Elsevier.
Tsai HK, et al. (2007). Androgen deprivation therapy
for localized prostate cancer and the risk of cardiovascular mortality.
Journal of the National Cancer Institute, 99(20):
1516-1524.
Tunn U (2007). The current status of intermittent
androgen deprivation (IAD) therapy for prostate cancer: Putting IAD under the
spotlight. British Journal of Urology International,
99(Suppl 1): 19-24.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
American Cancer Society (2006). Cancer Facts and Figures 2006, pp. 1-56. Atlanta: American
Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.
Kantoff PW (2007). Prostate cancer. In DC Dale, DD
Federman, eds., ACP Medicine, section 12, chap. 9. New
York: WebMD.
Gronberg H (2003). Prostate cancer epidemiology.
Lancet, 361(9360): 859-864.
U.S. Preventive Services Task Force (2003). Screening
for prostate cancer: Recommendations and rationale. American Family Physician, 67(4): 787-792.
National Institutes of Health (2007). Prostate cancer genetics: Fact sheet. Available online: http://www.nih.gov/about/researchresultsforthepublic.
Klein EA, et al. (2007). Epidemiology, etiology, and
prevention of prostate cancer. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2854-2873.
Philadelphia: Saunders Elsevier.
Robbins C, et al. (2007). Confirmation study of
prostate cancer risk variants at 8q24 in African Americans identifies a novel
risk locus. Genome Research, 17(12):
1717-1722.
National Cancer Institute (2007). Prostate Cancer (PDQ): Prevention-Health Professional Version.
Available online:
http://www.nci.nih.gov/cancertopics/pdq/prevention/prostate/HealthProfessional.
Bill-Axelson A, et al. (2005). Radical prostatectomy
versus watchful waiting in early prostate cancer. New England Journal of Medicine, 352(19): 1977-1984.
Punglia RS, et al. (2003). Effect of verification bias
on screening for prostate cancer by measurement of prostate-specific antigen.
New England Journal of Medicine, 349(4):
335-342.
Scher HI, et al. (2005). Cancer of the prostate. In VT
DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., pp. 1192-1259. Philadelphia: Lippincott Williams
and Wilkins.
Badani KK, et al. (2007). Evolution of robotic radical
prostatectomy: Assessment after 2,766 procedures. Cancer, 110(9): 1951-1958.
Brada M, et al. (2007). Proton therapy in clinical
practice: Current clinical evidence. Journal of Clinical Oncology, 25(8): 965-970.
D'Amico AV, et al. (2007). Radiation therapy for
prostate cancer. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 3006-3031. Philadelphia: Saunders
Elsevier.
Iversen P, et al. (2004). Bicalutamide (150 mg) versus
placebo as immediate therapy alone or as adjuvant to therapy with curative
intent for early nonmetastatic prostate cancer: 5.3-year median followup from
the Scandinavian Prostate Cancer Group Study No. 6. Journal of Urology, 172(5, Part 1): 1871-1876.
Agency for Healthcare Research and Quality (2008).
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Executive Summary (AHRQ Pub. No. 08-EHC010-1).
Rockville, MD: Agency for Healthcare Research and Quality. Available online:
http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=9&DocID=79.